Research
Study: Gemcitabine helps prevent recurrence of low-grade bladder cancer
May 16, 2018A multi-institution clinical trial involving researchers from UT Health San Antonio shows significantly lower recurrence of bladder cancer in patients who received the chemotherapy drug gemcitabine.
Read moreAudio spots focus on the how and why of what we do at UT Health San Antonio
May 7, 2018To help increase awareness and preference for our organization, UT Health San Antonio has launched a highly visible ad campaign.
Read more
Trend shows later onset of dementia, fewer years of the disease
April 24, 2018Findings could be related to reduced stroke risk.
Read moreFour trainees to present at American Association of Immunologists meeting
April 23, 2018Four trainees in the Infection, Inflammation and Immunity (III) discipline of the Integrated Biomedical Sciences Ph.D. program and Department of Microbiology, Immunology and Molecular Genetics will make podium presentations in the upcoming American Association of Immunologists Annual Meeting in Austin, May 4-8. Read their stories
Read moreFDA panel recommends CBD medication for epilepsy
April 20, 2018se E. Cavazos, M.D., Ph.D., professor of neurology and physiology at UT Health San Antonio and assistant dean of the institution’s M.D./Ph.D. program, reviewed clinical studies of the drug, which would be sold under the brand name Epidiolex.
Read moreAnnual dental symposium features posters, talks, new mentor award
April 18, 2018The symposium celebrates accomplishments in all areas of research, including education, public health, clinical sciences and basic sciences.
Read more